Morning Session
Conflict of Interest in Basic and Translational Research
7:30
Continental breakfast
8:15-8:35
Welcome, introductions, and chair’s statement
Bernard Lo, M.D., Committee Chair
8:35-9:00 Additional perspectives: professional society policies
Kenneth Kaushansky, M.D.
President, American Society of Hematology
Helen M. Ranney Professor and Chair, Department of Medicine
University of California, San Diego
9:00-10:10 Perspectives on financial relationships and conflicts of interest in basic and early-stage translational research: Part 1
Leslie Z. Benet, Ph.D.
Professor, Department of Biopharmaceutical Sciences
University of California San Francisco
Gail Cassell, Ph.D.
Vice President, Scientific Affairs and
Distinguished Lilly Research Scholar for Infectious Diseases
Eli Lilly and Company
Edward Benz, M.D.
President, Dana-Farber Cancer Institute
10:10-10:30 Break
10:30-11:25 Perspectives on financial relationships and conflicts of interest in basic and early-stage translational research: Part 2
Hamilton Moses, III, M.D.
Chair, The Alerion Institute
Leo Furcht, M.D.
Past President, Federation of American Societies for Experimental Biology
Allen Pardee Professor and Head of Lab Medicine and Pathology
University of Minnesota School of Medicine
11:25-Noon Financial disclosures and trust in health care professionals
Mark Hall, J.D.
Professor of Law and Public Health
Wake Forest University School of Law
Kevin Weinfurt, Ph.D.
Associate Professor of Psychiatry and Behavioral Sciences
and of Psychology and Neuroscience
Duke Clinical Research Institute
Noon-1:00 Lunch
Afternoon Session
Conflict of Interest in Clinical Practice Guidelines
1:00-1:15
Welcome, introductions, and chair’s statement
Bernard Lo, M.D., Commitee Chair
1:15-2:00 Individual and organizational financial relationships with industry
Elizabeth Boyd, Ph.D.
Assistant Vice President for Research, Compliance and Policy
University of Arizona
Mary Nix, M.S.
Health Scientist Administrator, National Guidelines Clearinghouse
Agency for Healthcare Research and Quality
2:00-3:00 Organizational policies, practices, and challenges in developing and implementing conflict-of-interest and related policies
American Society of Clinical Oncology
Dina Michels, Esq.
Vice President and General Counsel
American Academy of Neurology
Murray Sagsveen, J.D.
General Counsel
American College of Cardiology
Sidney C. Smith, Jr., M.D.
Professor of Medicine and Director, Academic Center for Cardiovascular Disease
University of North Carolina
U.S. Preventive Services Task Force
Mary Barton, M.D., M.P.P.
Scientific Director, USPSTF
Agency for Healthcare Research and Quality
Discussants:
Fran Visco, President, National Breast Cancer Coalition
Alvin Lever, M.A., CEO
Sandra Zelman Lewis, Ph.D., Assistant Vice President
American College of Chest Physicians
Henry Masur, M.D., Chief, Department of Critical Care Medicine
NIH Clinical Center
John C. Ring, M.D., Director, Policy Research and Development
American Heart Association
3:00-3:20 Break
3:20-4:00 Continued discussion of organizational policies and practices
4:00-5:00 Systematic reviews and other strategies to protect against bias in guidelines development
Holger Schunemann, M.D., Ph.D.
Associate Professor of Medicine
University of Buffalo and Italian National Cancer Institute (Rome)
5:00-5:30
Public comment
5:30
Adjourn